GB0027808D0
|
|
The use of nucleic acid to maximise the sensitivity and specificity of detection methods exploiting antibodies or other binding entities
|
GB0027650D0
|
|
Labelled polyanionic dyes as a method to separate prion from normal protein
|
GB0004528D0
|
|
The use of polysulphate polyglycosides for treatment or prophylactic use in inflammatory bowel diseases of animals or humans
|
GB0003049D0
|
|
Polyanionic polyglycosides as histopatholoical stains for amycoid
|
GB0003048D0
|
|
The therapeutic use of polysulphonated polyglycosides or other polyanionic compounds in autism
|
GB0003050D0
|
|
Labelled polyanionic polyglywsidens as a method to separarte prion from normal forms of proteins
|
GB0001765D0
|
|
Polysulphonated polyglycosides,including heparin and pentosan polysulphate as treatments for autism
|
GB9927756D0
|
|
A highly sensitive and specific method for the indication of anigenic or chemically adherent biochemical sites using nucleic acid
|
GB9913249D0
|
|
A highly sensitive and specific method for the demonstration of antigenic or chemically adherent biochemical sites using nucleic acid
|
GB9816152D0
|
|
A specific and sensitive method for the seeking of the prion form of the prion protein in various fluids and tissues
|
GB9713873D0
|
|
The formation of a specific test for amyloid
|
GB9700556D0
|
|
A specific and sensitive method for the diagnosis of transmissible spongiform encehalopathy (TSE)
|
GB9622211D0
|
|
Specific chemicals active against prion infection
|
GB9424725D0
|
|
Gene therapy in the treatment of Alzheimer's disease (AD)or any of the transmissible spongiform encephalopathies (TSEs)
|
GB9325831D0
|
|
Specefic chemicals active against prion infection
|
GB9210783D0
|
|
The extraction and use of chemicals from the common daisy (bellis perennis)and other specific plants for the treatment of human and animal illness
|
GB9122094D0
|
|
Pharmaceutical chemicals usable for diagnosis and for treatment of prion linked disease
|
GB8912406D0
|
|
Chemical indicator of butyryl esterase activity
|